As Duke’s Vice President for Research & Innovation Jenny Lodge wrote to our research community this weekend, the National Institutes of Health (NIH) announced on Friday that it would immediately cap reimbursement of facilities and administrative (F&A) costs on research grants at 15%, drastically reducing a critical source of support for biomedical research. This abrupt shift in policy would significantly slow or halt discovery in critical areas such as cancer, Alzheimer’s, infectious diseases, and pediatric health, eliminating roughly $194 million in annual research funding from NIH at Duke alone.